Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/18/10 → 6/30/13 |
Financiación
- Janssen Alzheimer Immunotherapy Research and Development LLC: 16.772,00 US$
Study of Bapineuzumab (AAB-001) Administered Subcutaneously At Monthly Intervals in Subjects with Mild to Moderate AD
- Jicha, Gregory (PI)
- Caban-Holt, Allison (CoI)